MJ Biz report..
As public health-insurance payouts for medical cannabis in Germany stagnate, entrepreneurs are focusing instead on the private health-care sector, where medical consultations and marijuana is paid for directly by patients.
Although Germany is often touted as an attractive market because statutory health insurers are expected to cover the cost of medical marijuana, opportunities in the private market could be even more attractive for some companies.
Stefan Fritsch, founder of Grünhorn, a pharmacy in Leipzig that specializes in medical cannabis, believes the private market is growing strong.
Read full piece